Tracxn Technolo. (TRACXN)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Latest quarterly sales of ₹21 Cr show the franchise still generates meaningful revenue.
• Sales decline is limited to -1.64%, indicating relative stability in the top line.
• Book value is positive at ₹6.56 per share, offering some asset backing.
• ROCE of 7.90% is positive, suggesting operations are not completely value-destructive.
• Promoter holding of 34.44% provides some owner alignment.

Concerns

• ROE of -18.50% and latest quarterly net loss of ₹1 Cr show current operations are destroying shareholder equity.
• Annual profit growth of -94.37% implies a severe earnings collapse; no P/E means no earnings support for valuation.
• P/B of 5.23 is rich for a company with negative returns; the price is far above book value of ₹6.56.
• Piotroski F-score of 3/9 suggests weak financial health and elevated operating risk.

AI Analysis

Tracxn, at ₹34.33, carries a market cap of ₹362 crore. As a Graham-Buffett practitioner, I first ask what earnings power I am buying. The honest answer is: none right now. Latest quarter shows ₹21 Cr sales and a ₹1 Cr loss; annual profit growth is down 94.37%, and ROE is a negative 18.50%. With no P/E, there are no normalized earnings to pay for. The price-to-book is 5.23 against ₹6.56 book value, so I am paying over five times net assets for a business destroying equity. The Piotroski score of 3/9 reinforces the message: the financial condition has deteriorated. Sales are essentially flat, -1.64%, so this is not a growth story either. ROCE of 7.90% looks only average and is far below what the high price-to-book multiple implicitly demands. No dividend means I receive no income while waiting. Promoter holding at 34.44% provides some alignment, but it is not a moat. I do not see a durable competitive advantage in these figures; a data processing firm might have information products and some switching costs, but the numbers show no pricing power or capital efficiency. Graham taught to buy with a margin of safety—price considerably below intrinsic value. Here, I have no such protection. If this is a turnaround, I cannot identify the catalyst; if it is a value trap, the price could keep falling toward the 52-week low of ₹25.39. I would prefer a profitable, debt-light business with rising sales and expanding returns. Tracxn needs to prove it can return to consistent profitability before I would consider it. Until then, I will keep it on the sidelines.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer